Roberto De Masi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Multiple Sclerosis

Cerebrospinal Fluid

Top Venues

International journal of molecular sciences

International journal of environmental research and public health

Pharmaceuticals (Basel, Switzerland)

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Roberto De Masi, Stefania Orlando, Vincenzo Toni, Maria Carmela Costa
Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report. International journal of molecular sciences 24 (3) (2023)
Roberto De Masi, Stefania Orlando, Vincenzo Toni, Maria Carmela Costa
Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report. International journal of molecular sciences 24 (3) (2023)
Roberto De Masi, Stefania Orlando, Vincenzo Toni, Maria Carmela Costa
Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report. International journal of molecular sciences 24 (3) (2023)
Roberto De Masi, Stefania Orlando, Chiara Leo, Matteo Pasca, Luca Anzilli, Maria Carmela Costa
Multi-Criterial Model for Weighting Biological Risk Factors in Multiple Sclerosis: Clinical and Health Insurance Implications. Healthcare (Basel, Switzerland) 11 (17) (2023)
Roberto De Masi, Stefania Orlando, Maria Carmela Costa
Dementia-Associated Compulsive Singing (DACS): Presentation of Unpublished Clinical Cases Miniseries. International journal of environmental research and public health 19 (17) (2022)
Roberto De Masi, Stefania Orlando
GANAB and N -Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. International journal of molecular sciences 23 (13) (2022)
Roberto De Masi, Stefania Orlando, Silvia Armenise, Pantaleo Spagnolo, Ruggero Capra, Maria Carmela Costa
Changes in Brain Volumes Are Relevant during Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: Lessons from a Case Report. International journal of molecular sciences 23 (21) (2022)
Roberto De Masi, Stefania Orlando, Antonella De Donno
The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Roberto De Masi, Stefania Orlando, Francesco Bagordo, Tiziana Grassi
IFP35 Is a Relevant Factor in Innate Immunity, Multiple Sclerosis, and Other Chronic Inflammatory Diseases: A Review. Biology 10 (12) (2021)
Giovanni Imbriani, Alessandra Panico, Tiziana Grassi, Adele Idolo, Francesca Serio, Francesco Bagordo, Giovanni De Filippis, Donato De Giorgi, Gianfranco Antonucci, Prisco Piscitelli, Manuela Colangelo, Luigi Peccarisi, Maria Rosaria Tumolo, Roberto De Masi, Alessandro Miani, Antonella De Donno
Early-Life Exposure to Environmental Air Pollution and Autism Spectrum Disorder: A Review of Available Evidence. International journal of environmental research and public health 18 (3) (2021)
Roberto De Masi, Stefania Orlando
GANAB as a Novel Biomarker in Multiple Sclerosis: Correlation with Neuroinflammation and IFI35. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Alessandra Panico, Maria Rosaria Tumolo, Carlo Giacomo Leo, Antonella De Donno, Tiziana Grassi, Francesco Bagordo, Francesca Serio, Adele Idolo, Roberto De Masi, Saverio Sabina
The influence of lifestyle factors on miRNA expression and signal pathways: a review. Epigenomics 13 (2) (2020)
Roberto De Masi, Stefania Orlando, Antonella De Donno
Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity. Annals of clinical and translational neurology 6 (11) (2019)